miércoles, 9 de abril de 2025

Safety, pharmacokinetics, and early bactericidal activity of quabodepistat in combination with delamanid, bedaquiline, or both in adults with pulmonary tuberculosis: a randomised, active-controlled, open-label trial

https://www.thelancet.com/journals/laninf/article/PIIS1473-3099(24)00601-7/fulltext?dgcid=hubspot_update_feature_updatealerts_laninf&utm_campaign=update-laninf&utm_medium=email&_hsenc=p2ANqtz-9WUDP1qABA-8cbIwYYOwcFx7cP0R2xJiIVhG3HEcjhVGXVUwkYYogoSjLl7q-iCfuib7w2ZMU-_FImGQ5WbUEPCXwxAg&_hsmi=355748901&utm_content=355699869&utm_source=hs_email

No hay comentarios:

Publicar un comentario